Jobs
岗位职责:
- 负责建立,完善车间培训体系;
- 收集部门的培训需求,根据公司及车间发展规划,制定落实公司年度培训计划和车间,岗位培训计划;
- 设计培训课件及培训考核内容;
- 开发内部培训资源,组织,督促各岗位内 训及培训考核;
- 挖掘,培养内部培训师,组织内部培训师培训,提高讲师的培训能力;
- 组织实施新员工培训及老员工的再培训,包括但不限于岗位SOP、SMP、MBR、OJT培训;
- 设计、开发培训效果评价体系,量化分析总结,持续改进;
- 负责车间文件和记录的领用,发放,回收,归档和备份,保证文件的安全性,保密性和有效性;
- 作为车间与其它部门对接的端口,跟踪文件签批进度,确保文件/记录在规定时间内完成修订及生效,以保证生产高效,有序进行;
- 领导安排的其它工作。
任职要求:
- 熟悉大分子生物制剂车间GMP要求;
- 6年以上药企业文件管理及培训相关工作经验,外企或国内头部生物药企业工作经验优先;
- 有独立开发和设计培训课件的能力;
- 良好的演讲能力;
- 了解多种培训方式,懂得如何实现更好的培训效果;
- 积极上进,学习能力强,执行力强,有大局观,工作效率高,善于沟通;
- 良好的英语听、说、读、写能力。
Total Views
0
Apply Clicks
0
Weekly mock applicants
0
Bookmarks
0
Similar jobs
About BioNTech

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
Employees
Mainz that develops immunotherapies
Headquarters
$21.7B
Valuation
Reviews
4.0
10 reviews
Work-life balance
2.5
Compensation
3.8
Culture
4.2
Career
3.5
Management
3.2
75%
Recommend to a friend
Pros
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
Cons
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
Salary Ranges
70 data points
L2
L3
L4
L5
L6
Mid/L4
Intern
L2 · Data Scientist L2
0 reports
$53,767
total per year
Base
$21,507
Stock
$26,884
Bonus
$5,377
$37,637
$69,897
Interview experience
1 interviews
Difficulty
3.0
/ 5
Duration
14-28 weeks
Interview process
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
Common questions
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
News & Buzz
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
1d ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
3d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
6d ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
6d ago




